LD-2 disclosure · 3rd Quarter - Report
INCYTE CORPORATION
Expenses$360Kself-filed spend
Client
- Location
- Delaware · United States of America
Registrant
- Description
- Biopharmaceutical Company
- Location
- Wilmington, Delaware, United States of America
Lobbying activities
1 issueMedicare/Medicaid
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B pricing reform; Issues related to Medicaid Rebates; Issues related to 340B; Issues related to coverage decisions in FEP
Lobbyistsms MELISSA WIER BANASHAK
TargetedSENATE · HOUSE OF REPRESENTATIVES